Le Lézard
Classified in: Health
Subject: PDT

InventHelp Inventor's WONDER EYE Allows for Efficient, Sanitary Eye Cleaning (MIS-300)


PITTSBURGH, May 23, 2018 /PRNewswire/ -- After getting something stuck in his eye and struggling to remove it, an inventor from St. Paul, Minn., decided that there should be a better way of performing this delicate task. "The patent-pending WONDER EYE is what I came up with to meet that need," he said.

InventHelp Logo (PRNewsfoto/InventHelp)

This device enables a user to clean his or her eyes in a convenient, reliable manner. It improves sanitation, which helps avoid infection. Overall, it removes debris from eyes quickly and with minimal effort. Ergonomic, versatile and easy to use, WONDER EYE is designed to promote comfort and peace of mind for the general population.

The original design was submitted to the Minneapolis office of InventHelp. It is currently available for licensing or sale to manufacturers or marketers. For more information, write Dept. 16-MIS-300, InventHelp, 217 Ninth Street, Pittsburgh, PA 15222, or call (412) 288-1300 ext. 1368. Learn more about InventHelp's Invention Submission Services at http://www.InventHelp.com.

SOURCE InventHelp


These press releases may also interest you

at 09:45
Proov, the creator of a suite of at-home fertility-related hormone tests, has announced today that an equity share of the company has been purchased by GRAMMY award-winning singer-songwriter, actor and author Ashanti and her fiancé, GRAMMY winning,...

at 09:38
The National Council on Aging (NCOA), the national voice for every person's right to age well, is hosting its 2024 Age+Action Conference on May 6-8, 2024, in Arlington, VA....

at 09:35
Prevent Blindness, the nation's leading nonprofit eye health and safety organization, has designated May as "Inherited Retinal Disease (IRD) Genetic Testing Awareness Month," expanding its previous IRD and Genetic Testing Awareness Week initiative....

at 09:30
Children's Minnesota and Minnesota Epilepsy Group are pleased to announce the re-accreditation of their epilepsy monitoring unit as a Level 4 Epilepsy Center. This accreditation is the highest of its kind by the National Association of Epilepsy...

at 09:30
Co-Diagnostics, Inc.  (the "Company" or "Co-Dx"), a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests, announced today that the Company will be hosting a booth and delivering a...

at 09:30
Alaffia Health, the leader in generative AI for health plan claim operations, today announced $10M in Series A funding, bringing its total amount of capital raised to $17.6M. The round was led by FirstMark Capital, with participation from GingerBread...



News published on and distributed by: